Coulter Partners

Coulter Partners Top hires for VC & PE portfolio companies Q2-2024

Coulter Partners recently partnered with Compass Pathways (Nasdaq: CMPS) (“Compass”) and is pleased to announce the placement of senior leadership team figures.

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, recently partnered with Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, and is pleased to announce the placement of Matthew (“Matt”) Sassone as Chief Executive Officer (“CEO”) and to the Tristel Board, with effect from 2 September 2024.

London, October 3, 2024 – Coulter Partners recently partnered with MTIP and the Nitinotes Board to conduct a successful search for a new Chief Executive Officer (“CEO”) for Nitinotes.

London, September 26, 2024 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, recently partnered with CellCentric and is pleased to announce the placement of Andy Fergus as Chief Development Officer. Andy joined CellCentric in September 2024, and is Boston based.

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, recently partnered with IMU Biosciences and is pleased to announce the placements of Dr John Baker as Chief Executive Officer and Dr Jason Brown as Chief Business Officer.

Coulter Partners recently partnered with T-Therapeutics and is pleased to announce the placement of David Hung as Chair of its Board of Directors.

Coulter Partners successfully completed a search assignment for ArcticZymes Technologies ASA (OSE: AZT) and is pleased to announce the placement of Dr. Frank Mathias as Chair of the Board.